Recruited 6 months ago to lead the US vaccine strategy, Belgian-Moroccan Moncef Slaoui resigned Tuesday January 12 at the request of the Biden team. Dr Slaoui will step down in a month, after leading the unprecedented effort of the US government to develop a safe and effective vaccine against Covid-19 before the end of 2020. The Moroccan-American immunologist had previously announced his intention to resign a once two vaccines and two therapies for Covid-19 were on the market, a goal that was achieved last month with the approval by U.S. health officials of Moderna and Pfizer’s vaccines. Although the vaccination campaign has not been as rapid as expected in the United States, the speed of vaccine development, overseen by Dr Slaoui, has exceeded expectations. Two vaccines have been authorized in the United States with 95% effectiveness against the virus in less than a year.
Trending
- 2026 World Cup: Morocco and Senegal face Wall Street algorithms
- Ecobank TI pays out $40 million in dividends: how to mitigate the paradox of the pan-African champion?
- Harvest Asset Management surpasses the one billion euros mark in assets under management and consolidates its leadership in the CEMAC zone
- MOTA 2026: High-level African and international participation to accelerate mining investments
- African Development Bank: Sidi Ould Tah initiates a deep overhaul of the organizational structure (exclusive)
- Hydrocarbons: TotalEnergies Marketing Côte d’Ivoire distributes 10 billion FCFA in dividends despite a decrease in profits
- Burkina Faso – Benin: Romuald Wadagni and Ibrahim Traoré revive the Ouagadougou-Cotonou axis
- National Development Plan (PND) 2026-2030: Ivory Coast is betting on the private sector
